kabutan

TOWA PHARMACEUTICAL CO.,LTD.(4553) Summary

4553
TSE Prime
TOWA PHARMACEUTICAL CO.,LTD.
3,525
JPY
+35
(+1.00%)
Dec 15, 3:30 pm JST
22.74
USD
Dec 15, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
9.8
PBR
0.96
Yield
2.27%
Margin Trading Ratio
4.96
Stock Price
Dec 15, 2025
Opening Dec 15, 9:00 am
3,500 JPY 22.45 USD
Previous Close Dec 12
3,490 JPY 22.40 USD
High Dec 15, 9:08 am
3,550 JPY 22.79 USD
Low Dec 15, 9:00 am
3,490 JPY 22.39 USD
Volume
128,900
Trading Value
0.45B JPY 2.93M USD
VWAP
3520.34 JPY 22.71 USD
Minimum Trading Value
352,500 JPY 2,274 USD
Market Cap
0.18T JPY 1.17B USD
Number of Trades
545
Liquidity & Number of Trades
As of Dec 15, 2025
Liquidity
Slightly High
1-Year Average
505
1-Year High May 16, 2025
2,469
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 44,500 38,900 0.87
Nov 28, 2025 37,400 91,900 2.46
Nov 21, 2025 36,500 107,100 2.93
Nov 14, 2025 31,900 128,500 4.03
Nov 7, 2025 32,200 141,000 4.38
Company Profile
TOWA PHARMACEUTICAL CO.,LTD. is a leading generic drug manufacturer with strengths in cardiovascular products. The company has expanded from serving clinics to pharmacies and has also entered the healthcare business.
Sector
Pharmaceuticals
TOWA PHARMACEUTICAL CO.,LTD. specializes in the manufacture and sale of prescription drugs, ranking among the top domestic producers of generic medicines, its main product line. The company directly sells its self-manufactured pharmaceuticals to medical institutions, as well as to distributors, pharmaceutical wholesalers, and other manufacturers. Through its group companies, TOWA is also involved in active pharmaceutical ingredient research and production, soft capsule manufacturing, and the planning, development, and contract manufacturing of health foods. Internationally, the company operates generic drug businesses in Europe and the United States through its holding company. Its group companies have research, development, and manufacturing bases in Europe, where they conduct generic drug sales and contract research, development, and manufacturing services.